New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
11:57 EDTISRG, SYK, BVX, HARTIntuitive Surgical falls after guidance disappoints
Shares of Intuitive Surgical (ISRG), which makes and markets the da Vinci Surgical System, are falling after the company announced it would sell fewer systems in 2014 compared to the prior year. It also declined to provide revenue guidance for 2014. WHAT'S NEW: Last night, Intuitive Surgical reported Q4 EPS of $4.28 and revenue of $576.2M, both of which exceeded expectations of $3.83 and $558.46M, respectively. WHATíS NOTABLE: On the companyís Q4 earnings conference call, management said the company would likely sell fewer da Vinci systems in 2014 compared to 2013. It forecast 2014 procedures increasing 9%-12%, compared to a 16% increase in procedures for 2013. The company declined to provide revenue guidance for 2014, citing a lack of visibility. ANALYST REACTION: This morning, research firm Jefferies said the companyís outlook was conservative. Jefferies said that while Intuitive Surgical's lack of revenue and earnings guidance was indicative of near-term headwinds and uncertainties, its procedure guidance met expectations and was likely conservative. The firm said Intuitive's long-term growth prospects remained compelling, and it kept a Buy rating on the stock with a $480 price target. PRICE ACTION: In late morning trading, Intuitive Surgical fell $23.81, or about 5.4%, to $415.19 on heavy trading volume. The shares are down approximately 28% over the past twelve months. OTHERS TO WATCH: Intuitive Surgicalís competitors include Stryker (SYK), Bovie Medical (BVX), and Harvard Apparatus (HART).
News For ISRG;SYK;BVX;HART From The Last 14 Days
Check below for free stories on ISRG;SYK;BVX;HART the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 23, 2014
07:18 EDTISRGIntuitive Surgical price target raised to $500 from $465 at Jefferies
Subscribe for More Information
05:50 EDTISRGIntuitive Surgical upgraded to Buy from Hold at Stifel
Stifel upgraded Intuitive Surgical to Buy with a $600 price target following the company's better than expected Q2 results. Shares were also upgraded this morning at Raymond James.
05:49 EDTISRGIntuitive Surgical upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
July 22, 2014
18:33 EDTISRGOn The Fly: After Hours Movers
UP AFTER EARNINGS: Broadcom (BRCM), consensus up 3% after reporting second quarter results... Intuitive Surgical (ISRG), up 10.4%... Manhattan Associates (MANH), up 3%... Robert Half International (RHI), up 3.9%... Hawaiian Holdings (HA), up 3.1%... Microsoft (MSFT), up just under 1%... FMC Technologies (FTI), up 1.1%. ALSO HIGHER: Ballard Power Systems (BLDP), up 2.7% following purchase order from New Flyer Industries... Unwired Planet (UPIP), up 2.4% after filing a lawsuit against Microsoft for breach of contract. NOTABLE: Puma Biotechnology (PBYI), up 193.8% after reporting positive top line results from Phase III PB272 trial. DOWN AFTER EARNINGS: Xilinx (XLNX), down 8.7%... Apple (AAPL), down after reporting third quarter results and fourth quarter guidance... Juniper Networks (JNPR), down 4.7%... ALSO LOWER: Farmland Partners (FPI), down 3.8% after filing to sell 3.72M shares of common stock.
17:00 EDTISRGIntuitive Surgical narrows FY14 procedure growth view to 5%-8% from 2%-8%
Subscribe for More Information
16:57 EDTISRGIntuitive Surgical sees international procedure growth 'lumpy' QoQ
Subscribe for More Information
16:39 EDTISRGIntuitive Surgical sees capital pressures in most hospitals to continue
Subscribe for More Information
16:17 EDTISRGIntuitive Surgical reports Q2 adjusted EPS $3.73, GAAP EPS $2.77
Consensus $2.83. Intuitive Surgical ended Q2 with $2B in cash, cash equivalents, and investments, a decrease of $920M during the quarter, primarily reflecting the impact of $1B utilized during the quarter to repurchase shares of its common stock.
16:13 EDTISRGIntuitive Surgical rises after results, first look
Subscribe for More Information
16:06 EDTISRGIntuitive Surgical reports Q2 EPS $2.77, consensus $2.83
Subscribe for More Information
15:30 EDTISRGNotable companies reporting after market close
Subscribe for More Information
13:57 EDTISRGEarnings Preview: Intuitive Surgical share price flat over last 12 months
Subscribe for More Information
11:36 EDTISRGIntuitive Surgical July weekly volatility increases into Q2 and outlook
Subscribe for More Information
08:36 EDTSYKStryker appoints CEO Kevin Lobo as chairman
Subscribe for More Information
July 18, 2014
09:00 EDTSYKStryker price target raised to $92 from $87 at RW Baird
Baird raised its price target on Stryker to $92 from $87 citing valuation, organic sales growth, and solid risk/reward. The firm has an Outperform rating on the stock.
07:37 EDTISRGIntuitive Surgical Q2 expectations 'appear achievable,' says Jefferies
Jefferies says its hospital and surgeon channel checks increase its comfort level around initial Xi demand and overall placements ahead of Intuitive Surgical's Q2 results, though the firm cautions that visibility on utilization is low and procedures could come in below consensus. Jefferies thinks expectations for Q2 "appear achievable" since they incorporate near-term challenges. The firm keeps a Buy rating on the stock with a $465 price target.
July 17, 2014
16:09 EDTSYKStryker sees Q3 adjusted EPS $1.12-$1.16 , consensus $1.16
"If foreign currency exchange rates hold near current levels, we do not expect the impact on third quarter or full year net sales to be significant," the company said.
16:08 EDTSYKStryker sees FY14 adjusted EPS $4.75-$4.80, consensus $4.80
Now projecting full year organic sales growth to be in the range of 5.0%-6.0%, consensus $9.61B.
16:07 EDTSYKStryker reports Q2 adjusted EPS $1.08, consensus $1.08
Subscribe for More Information
15:26 EDTSYKNotable companies reporting after market close
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use